Answers are grounded in this paper and cite their sources.
Evaluates the impact of tirofiban on neurological deterioration in acute ischemic stroke, suggesting better patient outcomes.
Evidence supports using antiplatelet therapy in patients with acute ischemic stroke. However, neurological deterioration remains common under the currently recommended antiplatelet regimen, leading to poor clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: